Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Childs Nerv Syst. 2021 Mar;37(3):853-861. doi: 10.1007/s00381-020-04901-2. Epub 2020 Oct 3.
To develop postoperative surveillance protocols that yield efficient detection rates of tumor recurrence or progression using fewer imaging studies and less cost.
This is a retrospective cohort study of all pediatric craniopharyngioma patients who have been diagnosed and treated at Boston Children's Hospital (BCH) between 1990 and 2017. All statistical analyses were performed using Stata.
Eighty patients (43 males and 37 females) fulfilled the inclusion criteria. The mean age at time of diagnosis was 8.6 ± 4.4 years. The mean follow-up period was 10.9 ± 6.5 years. Overall 30/80 (37.5%) patients experienced tumor recurrence/progression. The median latency to recurrence/progression was 12.75 months (range 3 to 108 months), with 76.6% of the recurrences/progressions taking place within the first 2 years postoperatively. Given the lack of any clinical symptoms/signs associated with the vast majority of the recurrent/progressed cases, we propose postoperative MR imaging surveillance protocols that are substantially less intensive than the current practice. Therefore, we recommend the following postoperative MR imaging surveillance protocols, stratified by management strategies; 0, 9, 15, 36, 48, and 60 months for patients who underwent GTR, 0, 3, 6,12, 18, and 24 months for patients who underwent STR alone and 0, 3, 12, 72, 96, and 120 months for patients who underwent STR followed by subsequent XRT.
The proposed postoperative MR imaging surveillance protocols would provide a potential 50% decrement of healthcare costs. It may also minify the psychological burden of frequent MR scanning for these patients and their families.
制定术后监测方案,通过减少影像学检查次数和降低成本,提高肿瘤复发或进展的检出率。
这是一项回顾性队列研究,纳入了 1990 年至 2017 年期间在波士顿儿童医院(BCH)被诊断和治疗的所有儿童颅咽管瘤患者。所有统计分析均使用 Stata 进行。
80 名患者(男 43 例,女 37 例)符合纳入标准。诊断时的平均年龄为 8.6 ± 4.4 岁。平均随访时间为 10.9 ± 6.5 年。共有 30/80(37.5%)例患者发生肿瘤复发/进展。复发/进展的中位潜伏期为 12.75 个月(范围 3 至 108 个月),76.6%的复发/进展发生在术后 2 年内。鉴于绝大多数复发性/进展性病例均无任何临床症状/体征,我们提出了术后磁共振成像监测方案,其强度明显低于目前的实践。因此,我们建议根据治疗策略,对接受 GTR 的患者采用以下术后磁共振成像监测方案:0、9、15、36、48 和 60 个月;对仅接受 STR 的患者采用 0、3、6、12、18 和 24 个月;对接受 STR 后行后续放疗的患者采用 0、3、12、72、96 和 120 个月。
拟议的术后磁共振成像监测方案可降低 50%的医疗保健成本。这也可能减轻这些患者及其家属因频繁磁共振扫描而带来的心理负担。